Cargando…

Role of Mineralocorticoid and Angiotensin Type 1 Receptors in the Paraventricular Nucleus in Angiotensin-Induced Hypertension

The hypothalamic paraventricular nucleus (PVN) is an important site where an interaction between circulating angiotensin (Ang) and mineralocorticoid receptor (MR) activity may modify sympathetic nerve activity (SNA) to influence long-term elevation of blood pressure. We examined in conscious Ang II-...

Descripción completa

Detalles Bibliográficos
Autores principales: Burke, Sandra L., Barzel, Benjamin, Jackson, Kristy L., Gueguen, Cindy, Young, Morag J., Head, Geoffrey A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982587/
https://www.ncbi.nlm.nih.gov/pubmed/33762970
http://dx.doi.org/10.3389/fphys.2021.640373
_version_ 1783667751224606720
author Burke, Sandra L.
Barzel, Benjamin
Jackson, Kristy L.
Gueguen, Cindy
Young, Morag J.
Head, Geoffrey A.
author_facet Burke, Sandra L.
Barzel, Benjamin
Jackson, Kristy L.
Gueguen, Cindy
Young, Morag J.
Head, Geoffrey A.
author_sort Burke, Sandra L.
collection PubMed
description The hypothalamic paraventricular nucleus (PVN) is an important site where an interaction between circulating angiotensin (Ang) and mineralocorticoid receptor (MR) activity may modify sympathetic nerve activity (SNA) to influence long-term elevation of blood pressure. We examined in conscious Ang II-treated rabbits, the effects on blood pressure and tonic and reflex renal SNA (RSNA) of microinjecting into the PVN either RU28318 to block MR, losartan to block Ang (AT(1)) receptors or muscimol to inhibit GABA(A) receptor agonist actions. Male rabbits received a moderate dose of Ang II (24 ng/kg/min subcutaneously) for 3 months (n = 13) or sham treatment (n = 13). At 3 months, blood pressure increased by +19% in the Ang II group compared to 10% in the sham (P = 0.022) but RSNA was similar. RU28318 lowered blood pressure in both Ang II and shams but had a greater effect on RSNA and heart rate in the Ang II-treated group (P < 0.05). Losartan also lowered RSNA, while muscimol produced sympatho-excitation in both groups. In Ang II-treated rabbits, RU28318 attenuated the blood pressure increase following chemoreceptor stimulation but did not affect responses to air jet stress. In contrast losartan and muscimol reduced blood pressure and RSNA responses to both hypoxia and air jet. While neither RU28318 nor losartan changed the RSNA baroreflex, RU28318 augmented the range of the heart rate baroreflex by 10% in Ang II-treated rabbits. Muscimol, however, augmented the RSNA baroreflex by 11% in sham animals and none of the treatments altered baroreflex sensitivity. In conclusion, 3 months of moderate Ang II treatment promotes activation of reflex RSNA principally via MR activation in the PVN, rather than via activation of AT(1) receptors. However, the onset of hypertension is independent of both. Interestingly, the sympatho-excitatory effects of muscimol in both groups suggest that overall, the PVN regulates a tonic sympatho-inhibitory influence on blood pressure control.
format Online
Article
Text
id pubmed-7982587
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79825872021-03-23 Role of Mineralocorticoid and Angiotensin Type 1 Receptors in the Paraventricular Nucleus in Angiotensin-Induced Hypertension Burke, Sandra L. Barzel, Benjamin Jackson, Kristy L. Gueguen, Cindy Young, Morag J. Head, Geoffrey A. Front Physiol Physiology The hypothalamic paraventricular nucleus (PVN) is an important site where an interaction between circulating angiotensin (Ang) and mineralocorticoid receptor (MR) activity may modify sympathetic nerve activity (SNA) to influence long-term elevation of blood pressure. We examined in conscious Ang II-treated rabbits, the effects on blood pressure and tonic and reflex renal SNA (RSNA) of microinjecting into the PVN either RU28318 to block MR, losartan to block Ang (AT(1)) receptors or muscimol to inhibit GABA(A) receptor agonist actions. Male rabbits received a moderate dose of Ang II (24 ng/kg/min subcutaneously) for 3 months (n = 13) or sham treatment (n = 13). At 3 months, blood pressure increased by +19% in the Ang II group compared to 10% in the sham (P = 0.022) but RSNA was similar. RU28318 lowered blood pressure in both Ang II and shams but had a greater effect on RSNA and heart rate in the Ang II-treated group (P < 0.05). Losartan also lowered RSNA, while muscimol produced sympatho-excitation in both groups. In Ang II-treated rabbits, RU28318 attenuated the blood pressure increase following chemoreceptor stimulation but did not affect responses to air jet stress. In contrast losartan and muscimol reduced blood pressure and RSNA responses to both hypoxia and air jet. While neither RU28318 nor losartan changed the RSNA baroreflex, RU28318 augmented the range of the heart rate baroreflex by 10% in Ang II-treated rabbits. Muscimol, however, augmented the RSNA baroreflex by 11% in sham animals and none of the treatments altered baroreflex sensitivity. In conclusion, 3 months of moderate Ang II treatment promotes activation of reflex RSNA principally via MR activation in the PVN, rather than via activation of AT(1) receptors. However, the onset of hypertension is independent of both. Interestingly, the sympatho-excitatory effects of muscimol in both groups suggest that overall, the PVN regulates a tonic sympatho-inhibitory influence on blood pressure control. Frontiers Media S.A. 2021-03-08 /pmc/articles/PMC7982587/ /pubmed/33762970 http://dx.doi.org/10.3389/fphys.2021.640373 Text en Copyright © 2021 Burke, Barzel, Jackson, Gueguen, Young and Head. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Physiology
Burke, Sandra L.
Barzel, Benjamin
Jackson, Kristy L.
Gueguen, Cindy
Young, Morag J.
Head, Geoffrey A.
Role of Mineralocorticoid and Angiotensin Type 1 Receptors in the Paraventricular Nucleus in Angiotensin-Induced Hypertension
title Role of Mineralocorticoid and Angiotensin Type 1 Receptors in the Paraventricular Nucleus in Angiotensin-Induced Hypertension
title_full Role of Mineralocorticoid and Angiotensin Type 1 Receptors in the Paraventricular Nucleus in Angiotensin-Induced Hypertension
title_fullStr Role of Mineralocorticoid and Angiotensin Type 1 Receptors in the Paraventricular Nucleus in Angiotensin-Induced Hypertension
title_full_unstemmed Role of Mineralocorticoid and Angiotensin Type 1 Receptors in the Paraventricular Nucleus in Angiotensin-Induced Hypertension
title_short Role of Mineralocorticoid and Angiotensin Type 1 Receptors in the Paraventricular Nucleus in Angiotensin-Induced Hypertension
title_sort role of mineralocorticoid and angiotensin type 1 receptors in the paraventricular nucleus in angiotensin-induced hypertension
topic Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982587/
https://www.ncbi.nlm.nih.gov/pubmed/33762970
http://dx.doi.org/10.3389/fphys.2021.640373
work_keys_str_mv AT burkesandral roleofmineralocorticoidandangiotensintype1receptorsintheparaventricularnucleusinangiotensininducedhypertension
AT barzelbenjamin roleofmineralocorticoidandangiotensintype1receptorsintheparaventricularnucleusinangiotensininducedhypertension
AT jacksonkristyl roleofmineralocorticoidandangiotensintype1receptorsintheparaventricularnucleusinangiotensininducedhypertension
AT gueguencindy roleofmineralocorticoidandangiotensintype1receptorsintheparaventricularnucleusinangiotensininducedhypertension
AT youngmoragj roleofmineralocorticoidandangiotensintype1receptorsintheparaventricularnucleusinangiotensininducedhypertension
AT headgeoffreya roleofmineralocorticoidandangiotensintype1receptorsintheparaventricularnucleusinangiotensininducedhypertension